Metaproterenol Inhalation and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Metaproterenol Inhalation and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: metaproterenol
Brand name: Metaprel, Alupent
Synonyms: Metaproterenol
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Metaproterenol Inhalation-Moxifloxacin
- Metaproterenol Inhalation-Moxifloxacin (Systemic)
- Metaproterenol Inhalation-Moxifloxacin Hydrochloride
- Metaproterenol Inhalation-Moxifloxacin Injection
- Metaproterenol Inhalation-Moxifloxacin Intravenous
- Metaproterenol Inhalation-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Metaproterenol Sulfate
- Moxetumomab pasudotox-tdfk Intravenous-Metaproterenol Syrup
- Moxetumomab pasudotox-tdfk Intravenous-Metaproterenol Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Metastron
- Moxetumomab pasudotox-tdfk Intravenous-Metatrace FDG
- Moxetumomab pasudotox-tdfk Intravenous-Metaxall